Latest News

Category: ASX

See all

Telix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET Technology

ASX, News,

Telix is pleased to announce the conclusion of collaboration and licensing agreement with CellSight Technologies, Inc. (CellSight) for the VisAcT immunoPET imaging technology...

Read more

Telix and Cyclotek Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New Zealand

ASX, News,

Telix is pleased to announce the completion of a Master Services Agreement with Cyclotek (Aust) Pty Ltd...

Read more

Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

ASX, News,

Telix is pleased to announce a licence agreement collaboration with Abzena plc (Abzena) for its prostate-specific membrane antigen antibodies...

Read more

Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer

ASX, News,

Telix is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS...

Read more

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

ASX, News,

Telix is pleased to announce a product development partnership with Therapeia GmbH & Co KG...

Read more